Vault-13

Eversept Partners, LP

NEW YORK, NY · CIK 1697013 · 13F filing filed 2026-05-15

SEC-registered investment adviser since 2017 · limited partnership

As an employer

Where they work

people there (dot area)number not reportedmain officeHover or tap a dot. Australian and UK companies are placed at their business or registered address, with their staff across the whole country.

Offices

From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.

CityCountryPeople
New York, NY (main office)United States United Statesabout 4
San Francisco, CAUnited States United States1

Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.

$1.5bn reported value -14.9% vs Q4 2025
104positions
52.6%in top 10
32 new 34 added 35 reduced 31 sold out vs Q4 2025

Options: 7 call positions ($89.0m notional), 9 put positions ($289.9m notional) – listed below, not included above.

Holdings, Q1 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 UNITED THERAPEUTICS CORP DEL COM UTHR UTHR 264,271 $156.7m10.33% 10.33% AddedShares held: Q2 2025 59.4k, Q3 2025 253.2k, Q4 2025 252.6k, Q1 2026 264.3k +11.7k +11,679 4.6%
2 ABIVAX SA SPONSORED ADS ABVX ABVX 934,423 $104.0m6.86% 6.86% AddedShares held: Q2 2025 0, Q3 2025 426.5k, Q4 2025 657.8k, Q1 2026 934.4k +276.6k +276,589 42.0%
3 GSK PLC SPONSORED ADR GSK GSK 1,785,175 $98.5m6.49% 6.49% ReducedShares held: Q2 2025 2.2m, Q3 2025 2.1m, Q4 2025 2.7m, Q1 2026 1.8m -894.5k -894,546 -33.4%
4 VERA THERAPEUTICS INC CL A VERA VERA 2,173,286 $87.4m5.76% 5.76% ReducedShares held: Q2 2025 2.4m, Q3 2025 2.8m, Q4 2025 3.1m, Q1 2026 2.2m -899.0k -899,018 -29.3%
5 NATERA INC COM NTRA NTRA 384,713 $76.9m5.07% 5.07% AddedShares held: Q2 2025 796.4k, Q3 2025 519.6k, Q4 2025 334.5k, Q1 2026 384.7k +50.2k +50,220 15.0%
6 SYNDAX PHARMACEUTICALS INC COM SNDX SNDX 2,885,622 $67.4m4.44% 4.44% ReducedShares held: Q2 2025 4.1m, Q3 2025 3.5m, Q4 2025 3.3m, Q1 2026 2.9m -428.8k -428,786 -12.9%
7 CELLDEX THERAPEUTICS INC NEW COM NEW CLDX CLDX 1,788,016 $56.7m3.74% 3.74% AddedShares held: Q2 2025 838.7k, Q3 2025 1.2m, Q4 2025 1.4m, Q1 2026 1.8m +353.3k +353,291 24.6%
8 VAXCYTE INC COM PCVX PCVX 924,193 $53.7m3.54% 3.54% ReducedShares held: Q2 2025 1.3m, Q3 2025 1.4m, Q4 2025 1.2m, Q1 2026 924.2k -273.5k -273,529 -22.8%
9 BROOKDALE SR LIVING INC COM BKD BKD 3,568,555 $48.8m3.22% 3.22% AddedShares held: Q2 2025 0, Q3 2025 0, Q4 2025 374.9k, Q1 2026 3.6m +3.2m +3,193,626 851.8%
10 IONIS PHARMACEUTICALS INC COM IONS IONS 632,100 $47.5m3.13% 3.13% AddedShares held: Q2 2025 588.9k, Q3 2025 538.7k, Q4 2025 538.2k, Q1 2026 632.1k +93.9k +93,882 17.4%
11 HCA HEALTHCARE INC COM HCA HCA 79,229 $37.5m2.47% 2.47% ReducedShares held: Q2 2025 100.0k, Q3 2025 111.7k, Q4 2025 95.9k, Q1 2026 79.2k -16.6k -16,645 -17.4%
12 WELLTOWER INC COM WELL WELL 180,953 $35.8m2.36% 2.36% NewShares held: Q2 2025 0, Q3 2025 0, Q4 2025 0, Q1 2026 181.0k
13 HEALTHPEAK PROPERTIES INC COM DOC DOC 1,981,070 $32.5m2.14% 2.14% NewShares held: Q2 2025 0, Q3 2025 0, Q4 2025 0, Q1 2026 2.0m
14 INSULET CORP COM PODD PODD 143,546 $30.1m1.99% 1.99% AddedShares held: Q2 2025 0, Q3 2025 45.6k, Q4 2025 74.7k, Q1 2026 143.5k +68.8k +68,838 92.1%
15 BIOCRYST PHARMACEUTICALS INC COM BCRX BCRX 3,039,820 $28.9m1.91% 1.91% AddedShares held: Q2 2025 1.2m, Q3 2025 1.4m, Q4 2025 3.0m, Q1 2026 3.0m +46.9k +46,925 1.6%
16 GERON CORP COM GERN GERN 18,834,883 $28.1m1.85% 1.85% AddedShares held: Q2 2025 7.3m, Q3 2025 12.6m, Q4 2025 17.7m, Q1 2026 18.8m +1.2m +1,174,900 6.7%
17 OMEGA HEALTHCARE INVS INC COM OHI OHI 585,680 $25.7m1.69% 1.69% NewShares held: Q2 2025 0, Q3 2025 0, Q4 2025 0, Q1 2026 585.7k
18 LIQUIDIA CORPORATION COM NEW LQDA LQDA 677,392 $25.6m1.68% 1.68% AddedShares held: Q2 2025 358.8k, Q3 2025 486.0k, Q4 2025 509.4k, Q1 2026 677.4k +167.9k +167,949 33.0%
19 COMMUNITY HEALTH SYS INC NEW COM CYH CYH 8,677,281 $25.5m1.68% 1.68% AddedShares held: Q2 2025 6.1m, Q3 2025 7.0m, Q4 2025 7.9m, Q1 2026 8.7m +733.5k +733,479 9.2%
20 AVANTOR INC COM AVTR AVTR 2,974,287 $23.3m1.54% 1.54% ReducedShares held: Q2 2025 1.5m, Q3 2025 924.4k, Q4 2025 3.2m, Q1 2026 3.0m -202.4k -202,357 -6.4%
21 QIAGEN NV ORD SHARES QGEN QGEN 545,330 $21.8m1.44% 1.44% NewShares held: Q2 2025 0, Q3 2025 0, Q4 2025 0, Q1 2026 545.3k
22 ENCOMPASS HEALTH CORP COM EHC EHC 194,104 $18.8m1.24% 1.24% AddedShares held: Q2 2025 0, Q3 2025 0, Q4 2025 106.9k, Q1 2026 194.1k +87.2k +87,178 81.5%
23 ELI LILLY & CO COM LLY LLY 19,000 $17.5m1.15% 1.15% AddedShares held: Q2 2025 0, Q3 2025 0, Q4 2025 10.6k, Q1 2026 19.0k +8.4k +8,377 78.9%
24 TRAVERE THERAPEUTICS INC COM TVTX TVTX 542,610 $16.1m1.06% 1.06% ReducedShares held: Q2 2025 1.3m, Q3 2025 1.4m, Q4 2025 1.2m, Q1 2026 542.6k -632.4k -632,358 -53.8%
25 CYTOMX THERAPEUTICS INC COM CTMX CTMX 3,188,514 $15.0m0.99% 0.99% AddedShares held: Q2 2025 0, Q3 2025 0, Q4 2025 2.5m, Q1 2026 3.2m +681.4k +681,424 27.2%
26 REPLIGEN CORP COM RGEN RGEN 120,785 $14.2m0.94% 0.94% NewShares held: Q2 2025 18.6k, Q3 2025 105.1k, Q4 2025 0, Q1 2026 120.8k
27 BETA BIONICS INC COM BBNX BBNX 1,414,838 $14.2m0.93% 0.93% AddedShares held: Q2 2025 0, Q3 2025 0, Q4 2025 678.3k, Q1 2026 1.4m +736.6k +736,576 108.6%
28 VIRIDIAN THERAPEUTICS INC COM VRDN VRDN 713,269 $14.0m0.92% 0.92% ReducedShares held: Q2 2025 1.9m, Q3 2025 1.9m, Q4 2025 1.8m, Q1 2026 713.3k -1.1m -1,068,966 -60.0%
29 ARCUTIS BIOTHERAPEUTICS INC COM ARQT ARQT 576,580 $13.6m0.90% 0.90% AddedShares held: Q2 2025 0, Q3 2025 111.5k, Q4 2025 434.6k, Q1 2026 576.6k +141.9k +141,946 32.7%
30 ARDELYX INC COM ARDX ARDX 2,229,446 $13.4m0.88% 0.88% AddedShares held: Q2 2025 0, Q3 2025 1.4m, Q4 2025 1.7m, Q1 2026 2.2m +514.3k +514,317 30.0%
31 LTC PPTYS INC COM LTC LTC 321,046 $11.9m0.79% 0.79% NewShares held: Q2 2025 0, Q3 2025 0, Q4 2025 0, Q1 2026 321.0k
32 BIOMARIN PHARMACEUTICAL INC COM BMRN BMRN 207,768 $11.7m0.77% 0.77% AddedShares held: Q2 2025 0, Q3 2025 146.6k, Q4 2025 93.7k, Q1 2026 207.8k +114.0k +114,020 121.6%
33 CHEMED CORP NEW COM CHE CHE 31,057 $11.7m0.77% 0.77% NewShares held: Q2 2025 0, Q3 2025 0, Q4 2025 0, Q1 2026 31.1k
34 PHARVARIS N V COM PHVS PHVS 406,960 $11.5m0.76% 0.76% ReducedShares held: Q2 2025 0, Q3 2025 0, Q4 2025 439.2k, Q1 2026 407.0k -32.2k -32,217 -7.3%
35 PENNANT GROUP INC COM PNTG PNTG 312,178 $9.5m0.63% 0.63% AddedShares held: Q2 2025 38.0k, Q3 2025 38.0k, Q4 2025 294.0k, Q1 2026 312.2k +18.2k +18,218 6.2%
36 NEWAMSTERDAM PHARMA COMPANY ORDINARY SHARES NAMS NAMS 285,764 $9.1m0.60% 0.60% ReducedShares held: Q2 2025 414.4k, Q3 2025 488.6k, Q4 2025 420.8k, Q1 2026 285.8k -135.1k -135,063 -32.1%
37 PALISADE BIO INC COM PALI PALI 4,987,499 $8.7m0.58% 0.58% ReducedShares held: Q2 2025 0, Q3 2025 0, Q4 2025 5.4m, Q1 2026 5.0m -404.0k -404,049 -7.5%
38 MODERNA INC COM MRNA MRNA 159,708 $8.1m0.53% 0.53% ReducedShares held: Q2 2025 0, Q3 2025 0, Q4 2025 267.8k, Q1 2026 159.7k -108.1k -108,115 -40.4%
39 VIKING THERAPEUTICS INC COM VKTX VKTX 239,110 $7.8m0.51% 0.51% NewShares held: Q2 2025 0, Q3 2025 0, Q4 2025 0, Q1 2026 239.1k
40 ICON PLC SHS ICLR ICLR 68,688 $7.6m0.50% 0.50% ReducedShares held: Q2 2025 64.6k, Q3 2025 55.0k, Q4 2025 95.8k, Q1 2026 68.7k -27.1k -27,144 -28.3%
41 XENON PHARMACEUTICALS INC COM XENE XENE 129,574 $7.5m0.50% 0.50% ReducedShares held: Q2 2025 0, Q3 2025 0, Q4 2025 231.4k, Q1 2026 129.6k -101.8k -101,806 -44.0%
42 REVVITY INC COM RVTY RVTY 84,854 $7.4m0.49% 0.49% ReducedShares held: Q2 2025 510.3k, Q3 2025 394.3k, Q4 2025 162.8k, Q1 2026 84.9k -77.9k -77,923 -47.9%
43 AGIOS PHARMACEUTICALS INC COM AGIO AGIO 200,000 $6.8m0.45% 0.45% NewShares held: Q2 2025 0, Q3 2025 0, Q4 2025 0, Q1 2026 200.0k
44 STRUCTURE THERAPEUTICS INC SPONSORED ADS GPCR GPCR 138,036 $6.7m0.44% 0.44% AddedShares held: Q2 2025 99.3k, Q3 2025 166.4k, Q4 2025 127.6k, Q1 2026 138.0k +10.5k +10,475 8.2%
45 BIO-TECHNE CORP COM TECH TECH 125,896 $6.6m0.43% 0.43% ReducedShares held: Q2 2025 394.1k, Q3 2025 591.5k, Q4 2025 377.4k, Q1 2026 125.9k -251.5k -251,509 -66.6%
46 GLAUKOS CORP COM GKOS GKOS 60,214 $6.5m0.43% 0.43% ReducedShares held: Q2 2025 31.5k, Q3 2025 0, Q4 2025 147.5k, Q1 2026 60.2k -87.3k -87,257 -59.2%
47 TENET HEALTHCARE CORP COM NEW THC THC 29,512 $5.6m0.37% 0.37% NewShares held: Q2 2025 0, Q3 2025 0, Q4 2025 0, Q1 2026 29.5k
48 MADRIGAL PHARMACEUTICALS INC COM MDGL MDGL 10,000 $5.2m0.34% 0.34% NewShares held: Q2 2025 0, Q3 2025 0, Q4 2025 0, Q1 2026 10.0k
49 INTUITIVE SURGICAL INC COM NEW ISRG ISRG 11,119 $5.1m0.34% 0.34% ReducedShares held: Q2 2025 0, Q3 2025 14.4k, Q4 2025 18.1k, Q1 2026 11.1k -6.9k -6,943 -38.4%
50 ESPERION THERAPEUTICS INC NE COM ESPR ESPR 1,735,963 $4.8m0.31% 0.31% ReducedShares held: Q2 2025 0, Q3 2025 0, Q4 2025 3.9m, Q1 2026 1.7m -2.1m -2,115,170 -54.9%
51 MOLINA HEALTHCARE INC COM MOH MOH 32,811 $4.4m0.29% 0.29% ReducedShares held: Q2 2025 20.6k, Q3 2025 9.5k, Q4 2025 45.5k, Q1 2026 32.8k -12.7k -12,659 -27.8%
52 HEALTHEQUITY INC COM HQY HQY 51,614 $4.3m0.28% 0.28% ReducedShares held: Q2 2025 155.9k, Q3 2025 52.4k, Q4 2025 185.7k, Q1 2026 51.6k -134.1k -134,125 -72.2%
53 BRUKER CORP COM BRKR BRKR 117,013 $4.2m0.28% 0.28% ReducedShares held: Q2 2025 839.3k, Q3 2025 687.1k, Q4 2025 783.8k, Q1 2026 117.0k -666.8k -666,776 -85.1%
54 DAY ONE BIOPHARMACEUTICALS I COM COM 183,902 $3.9m0.26% 0.26% NewShares held: Q2 2025 0, Q3 2025 0, Q4 2025 0, Q1 2026 183.9k
55 COMPASS PATHWAYS PLC SPONSORED ADS CMPS CMPS 677,924 $3.7m0.25% 0.25% NewShares held: Q2 2025 0, Q3 2025 0, Q4 2025 0, Q1 2026 677.9k
56 CENTENE CORP DEL COM CNC CNC 111,652 $3.7m0.24% 0.24% ReducedShares held: Q2 2025 398.7k, Q3 2025 224.6k, Q4 2025 324.1k, Q1 2026 111.7k -212.4k -212,440 -65.5%
57 GRACE THERAPEUTICS INC COM GRCE GRCE 756,600 $3.5m0.23% 0.23% NewShares held: Q2 2025 0, Q3 2025 0, Q4 2025 0, Q1 2026 756.6k
58 ENGENE HOLDINGS INC COM COM 510,543 $3.5m0.23% 0.23% AddedShares held: Q2 2025 0, Q3 2025 0, Q4 2025 455.8k, Q1 2026 510.5k +54.7k +54,708 12.0%
59 ENHABIT INC COM EHAB EHAB 227,451 $3.2m0.21% 0.21% AddedShares held: Q2 2025 0, Q3 2025 0, Q4 2025 218.5k, Q1 2026 227.5k +8.9k +8,941 4.1%
60 DEFINIUM THERAPEUTICS INC COM SHS DFTX DFTX 160,723 $3.0m0.20% 0.20% NewShares held: Q2 2025 0, Q3 2025 0, Q4 2025 0, Q1 2026 160.7k
61 EQUILLIUM INC COM EQ EQ 1,498,993 $3.0m0.20% 0.20% NewShares held: Q2 2025 0, Q3 2025 0, Q4 2025 0, Q1 2026 1.5m
62 ENSIGN GROUP INC COM ENSG ENSG 14,761 $3.0m0.20% 0.20% NewShares held: Q2 2025 0, Q3 2025 0, Q4 2025 0, Q1 2026 14.8k
63 INVIVYD INC COM IVVD IVVD 2,276,349 $3.0m0.20% 0.20% AddedShares held: Q2 2025 0, Q3 2025 2.0m, Q4 2025 2.1m, Q1 2026 2.3m +136.2k +136,219 6.4%
64 PMV PHARMACEUTICALS INC COM PMVP PMVP 2,348,360 $2.9m0.19% 0.19% NewShares held: Q2 2025 0, Q3 2025 0, Q4 2025 0, Q1 2026 2.3m
65 ALECTOR INC COM ALEC ALEC 1,351,106 $2.9m0.19% 0.19% AddedShares held: Q2 2025 2.0m, Q3 2025 1.5m, Q4 2025 1.0m, Q1 2026 1.4m +344.9k +344,943 34.3%
66 ALTO NEUROSCIENCE INC COM SHS ANRO ANRO 125,168 $2.8m0.19% 0.19% NewShares held: Q2 2025 0, Q3 2025 0, Q4 2025 0, Q1 2026 125.2k
67 RELAY THERAPEUTICS INC COM RLAY RLAY 270,705 $2.7m0.18% 0.18% ReducedShares held: Q2 2025 533.4k, Q3 2025 479.1k, Q4 2025 489.1k, Q1 2026 270.7k -218.4k -218,432 -44.7%
68 REPLIMUNE GROUP INC COM REPL REPL 334,861 $2.6m0.17% 0.17% NewShares held: Q2 2025 0, Q3 2025 60.0k, Q4 2025 0, Q1 2026 334.9k
69 LB PHARMACEUTICALS INC COM SHS LBRX LBRX 100,198 $2.5m0.16% 0.16% NewShares held: Q2 2025 0, Q3 2025 0, Q4 2025 0, Q1 2026 100.2k
70 LIPOCINE INC NEW COM NEW LPCN LPCN 294,989 $2.4m0.16% 0.16% NewShares held: Q2 2025 0, Q3 2025 0, Q4 2025 0, Q1 2026 295.0k
71 VIR BIOTECHNOLOGY INC COM VIR VIR 250,000 $2.2m0.15% 0.15% NewShares held: Q2 2025 0, Q3 2025 0, Q4 2025 0, Q1 2026 250.0k
72 ANTERIS TECHNOLOGIES GLOBAL COM AVR AVR 401,187 $2.2m0.15% 0.15% ReducedShares held: Q2 2025 0, Q3 2025 500.0k, Q4 2025 500.0k, Q1 2026 401.2k -98.8k -98,813 -19.8%
73 AMARIN CORP PLC SPONSORED ADR AMRN AMRN 147,715 $2.1m0.14% 0.14% ReducedShares held: Q2 2025 167.3k, Q3 2025 167.3k, Q4 2025 172.2k, Q1 2026 147.7k -24.5k -24,473 -14.2%
74 SAVARA INC COM SVRA SVRA 384,264 $2.1m0.14% 0.14% AddedShares held: Q2 2025 0, Q3 2025 0, Q4 2025 170.2k, Q1 2026 384.3k +214.1k +214,069 125.8%
75 RELMADA THERAPEUTICS INC COM RLMD RLMD 277,899 $1.9m0.13% 0.13% NewShares held: Q2 2025 0, Q3 2025 0, Q4 2025 0, Q1 2026 277.9k
76 CONTINEUM THERAPEUTICS INC CL A CTNM CTNM 146,411 $1.9m0.13% 0.13% AddedShares held: Q2 2025 0, Q3 2025 134.6k, Q4 2025 137.5k, Q1 2026 146.4k +8.9k +8,918 6.5%
77 SUTRO BIOPHARMA INC COM SHS STRO STRO 73,161 $1.8m0.12% 0.12% ReducedShares held: Q2 2025 0, Q3 2025 0, Q4 2025 193.6k, Q1 2026 73.2k -120.4k -120,410 -62.2%
78 INOVIO PHARMACEUTICALS INC COM SHS INO INO 1,035,360 $1.8m0.12% 0.12% NewShares held: Q2 2025 0, Q3 2025 0, Q4 2025 0, Q1 2026 1.0m
79 SURROZEN INC COM NEW SRZN SRZN 58,624 $1.7m0.11% 0.11% ReducedShares held: Q2 2025 0, Q3 2025 77.0k, Q4 2025 95.3k, Q1 2026 58.6k -36.7k -36,662 -38.5%
80 INFLARX NV COM IFRX IFRX 1,758,573 $1.6m0.10% 0.10% AddedShares held: Q2 2025 1.6m, Q3 2025 1.7m, Q4 2025 1.8m, Q1 2026 1.8m +1.3k +1,261 0.1%
81 KARYOPHARM THERAPEUTICS INC COM NEW KPTI KPTI 276,174 $1.5m0.10% 0.10% NewShares held: Q2 2025 257.2k, Q3 2025 0, Q4 2025 0, Q1 2026 276.2k
82 ANAPTYSBIO INC COM ANAB ANAB 27,089 $1.5m0.10% 0.10% ReducedShares held: Q2 2025 0, Q3 2025 0, Q4 2025 120.9k, Q1 2026 27.1k -93.8k -93,838 -77.6%
83 NOVOCURE LTD ORD SHS NVCR NVCR 134,917 $1.5m0.10% 0.10% AddedShares held: Q2 2025 0, Q3 2025 0, Q4 2025 121.0k, Q1 2026 134.9k +13.9k +13,939 11.5%
84 BIOVENTUS INC COM CL A BVS BVS 159,110 $1.5m0.10% 0.10% ReducedShares held: Q2 2025 0, Q3 2025 433.9k, Q4 2025 471.3k, Q1 2026 159.1k -312.1k -312,147 -66.2%
85 AGILON HEALTH INC COM NEW AGL AGL 176,588 $1.4m0.09% 0.09% NewShares held: Q2 2025 0, Q3 2025 0, Q4 2025 0, Q1 2026 176.6k
86 ULTRAGENYX PHARMACEUTICAL IN COM RARE RARE 62,575 $1.3m0.09% 0.09% ReducedShares held: Q2 2025 0, Q3 2025 0, Q4 2025 317.2k, Q1 2026 62.6k -254.6k -254,607 -80.3%
87 EVOMMUNE INC COM SHS EVMN EVMN 54,680 $1.3m0.08% 0.08% NewShares held: Q2 2025 0, Q3 2025 0, Q4 2025 0, Q1 2026 54.7k
88 IMMUNOCORE HLDGS PLC ADS IMCR IMCR 39,238 $1.2m0.08% 0.08% NewShares held: Q2 2025 0, Q3 2025 0, Q4 2025 0, Q1 2026 39.2k
89 ASSEMBLY BIOSCIENCES INC COM NEW ASMB ASMB 40,889 $1.1m0.07% 0.07% ReducedShares held: Q2 2025 0, Q3 2025 0, Q4 2025 159.7k, Q1 2026 40.9k -118.8k -118,787 -74.4%
90 PLIANT THERAPEUTICS INC COM PLRX PLRX 891,425 $1.1m0.07% 0.07% AddedShares held: Q2 2025 0, Q3 2025 824.6k, Q4 2025 842.0k, Q1 2026 891.4k +49.4k +49,402 5.9%
91 ARS PHARMACEUTICALS INC COM SPRY SPRY 136,235 $1.1m0.07% 0.07% ReducedShares held: Q2 2025 0, Q3 2025 976.5k, Q4 2025 251.6k, Q1 2026 136.2k -115.4k -115,358 -45.9%
92 AADI BIOSCIENCE INC COM WHWK WHWK 306,800 $1.1m0.07% 0.07% AddedShares held: Q2 2025 0, Q3 2025 0, Q4 2025 260.3k, Q1 2026 306.8k +46.5k +46,541 17.9%
93 TYRA BIOSCIENCES INC COM TYRA TYRA 27,055 $1.0m0.07% 0.07% ReducedShares held: Q2 2025 0, Q3 2025 272.7k, Q4 2025 278.6k, Q1 2026 27.1k -251.5k -251,509 -90.3%
94 PASSAGE BIO INC COM NEW PASG PASG 131,581 $1.0m0.07% 0.07% AddedShares held: Q2 2025 0, Q3 2025 0, Q4 2025 126.2k, Q1 2026 131.6k +5.4k +5,351 4.2%
95 DIVERSIFIED HEALTHCARE TR COM SH BEN INT DHC DHC 151,283 $1.0m0.07% 0.07% NewShares held: Q2 2025 0, Q3 2025 0, Q4 2025 0, Q1 2026 151.3k
96 INMODE LTD SHS INMD INMD 67,744 $926.7k0.06% 0.06% AddedShares held: Q2 2025 0, Q3 2025 0, Q4 2025 61.9k, Q1 2026 67.7k +5.8k +5,806 9.4%
97 SONIDA SENIOR LIVING INC COM SNDA SNDA 28,437 $917.1k0.06% 0.06% NewShares held: Q2 2025 0, Q3 2025 0, Q4 2025 0, Q1 2026 28.4k
98 BICYCLE THERAPEUTICS PLC SPONSORED ADS BCYC BCYC 190,715 $884.9k0.06% 0.06% AddedShares held: Q2 2025 211.5k, Q3 2025 194.4k, Q4 2025 178.9k, Q1 2026 190.7k +11.8k +11,800 6.6%
99 EDITAS MEDICINE INC COM EDIT EDIT 290,919 $718.6k0.05% 0.05% UnchangedShares held: Q2 2025 0, Q3 2025 0, Q4 2025 290.9k, Q1 2026 290.9k
100 SS INNOVATIONS INTERNATIONAL COM NEW SSII SSII 110,157 $550.8k0.04% 0.04% AddedShares held: Q2 2025 0, Q3 2025 0, Q4 2025 75.4k, Q1 2026 110.2k +34.8k +34,799 46.2%

Sold out since Q4 2025

SecurityTickerShares held beforeValue then
DANAHER CORPORATION DHR DHR 186,262 $42.6m186.3k shares
EXACT SCIENCES CORP EXAS EXAS 241,678 $24.5m241.7k shares
CIDARA THERAPEUTICS INC CDTX CDTX 98,721 $21.8m98.7k shares
TEVA PHARMACEUTICAL INDS LTD 660,177 $20.6m660.2k shares
UNITEDHEALTH GROUP INC UNH UNH 60,862 $20.1m60.9k shares
BIOGEN INC BIIB BIIB 77,944 $13.7m77.9k shares
SELECT MED HLDGS CORP SEM SEM 906,100 $13.5m906.1k shares
CG ONCOLOGY INC CGON CGON 308,466 $12.8m308.5k shares
BRISTOL-MYERS SQUIBB CO BMY BMY 235,293 $12.7m235.3k shares
ELEVANCE HEALTH INC ELV ELV 30,195 $10.6m30.2k shares
MANNKIND CORP MNKD MNKD 1,852,563 $10.5m1.9m shares
ASCENDIS PHARMA A/S 48,241 $10.3m48.2k shares
ILLUMINA INC ILMN ILMN 76,721 $10.1m76.7k shares
DYNAVAX TECHNOLOGIES CORP DVAX DVAX 605,976 $9.3m606.0k shares
EDGEWISE THERAPEUTICS INC EWTX EWTX 337,340 $8.4m337.3k shares
CATALYST PHARMACEUTICALS INC CPRX CPRX 358,168 $8.4m358.2k shares
HUMANA INC HUM HUM 32,462 $8.3m32.5k shares
REGENERON PHARMACEUTICALS REGN REGN 10,097 $7.8m10.1k shares
CVS HEALTH CORP CVS CVS 63,696 $5.1m63.7k shares
ACADIA PHARMACEUTICALS INC ACAD ACAD 176,594 $4.7m176.6k shares
PROTAGONIST THERAPEUTICS INC PTGX PTGX 52,961 $4.6m53.0k shares
ZENAS BIOPHARMA INC ZBIO ZBIO 121,016 $4.4m121.0k shares
NATIONAL HEALTHCARE CORP NHC NHC 28,577 $3.9m28.6k shares
FORTREA HLDGS INC FTRE FTRE 224,139 $3.9m224.1k shares
MARAVAI LIFESCIENCES HLDGS I MRVI MRVI 718,582 $2.3m718.6k shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
INVESCO QQQ TR QQQ · Put QQQPut 238,700 $137.8m238.7k shares Added
SPDR S&P 500 ETF TR SPY · Put SPYPut 107,000 $69.6m107.0k shares Added
VERTEX PHARMACEUTICALS INC VRTX · Call VRTXCall 90,000 $40.2m90.0k shares New
ISHARES TR TLT · Put TLTPut 428,800 $37.2m428.8k shares Added
QIAGEN NV QGEN · Call QGENCall 476,300 $19.1m476.3k shares New
INSMED INC INSM · Call INSMCall 94,000 $15.4m94.0k shares New
ISHARES TR HYG · Put HYGPut 180,000 $14.3m180.0k shares New
UNITEDHEALTH GROUP INC UNH · Call UNHCall 40,000 $10.8m40.0k shares New
ISHARES TR IWM · Put IWMPut 40,000 $9.9m40.0k shares New
SELECT SECTOR SPDR TR XLK · Put XLKPut 70,000 $9.3m70.0k shares New
PRAXIS PRECISION MEDICINES I PRAX · Put PRAXPut 14,800 $4.8m14.8k shares New
SPDR SER TR XBI · Put XBIPut 30,000 $3.8m30.0k shares Reduced
UNIVERSAL HLTH SVCS INC UHS · Put UHSPut 18,200 $3.3m18.2k shares New
SELECT SECTOR SPDR TR XLE · Call XLECall 50,000 $3.1m50.0k shares New
REPLIMUNE GROUP INC REPL · Call REPLCall 52,000 $397.8k52.0k shares New
KARYOPHARM THERAPEUTICS INC KPTI · Call KPTICall 23,800 $132.6k23.8k shares New

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
COMMUNITY HEALTH SYS INC NEW CYH · 13G · filed 2026-02-17 CYH 5.7%≈ $26.5m +1.3 pts 13G 2026-02-17